Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-07 · accession 0001214659-25-004223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-11 | 2025-03-07 | AQST | BRAENDER LORI J | CLO | A - Grant | $0.00 | +110.0K | 423.2K | +35% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | BRAENDER LORI J | CLO | F - Tax | $2.65 | -20.2K | 413.6K | -5% | -$53.7K |
| D | 2025-03-11 | 2025-03-07 | AQST | BRAENDER LORI J | CLO | A - Grant | $0.00 | +60.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | A | A | 110,000 | $0.00 | 423,231 | D | — | — | (F1) The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |
| 2 | Common | Common Stock | 2025-03-09 | F | D | 10,658 | $2.65 | 402,981 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. |
| 3 | Common | Common Stock | 2025-03-07 | F | D | 9,592 | $2.65 | 413,639 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-03-07 | A | A | 60,000 | $0.00 | 60,000 | D | $2.65 · — to 2035-03-07 | 60,000 Common Stock | (F3) The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. |